In early January 2026, Bayer’s subsidiaries and partners reported a series of R&D advances, including FDA acceptance of ...

Bayer's stock is undervalued and offers potential for long-term recovery. Revenues have been quite strong for a while. But earnings have not shown sustainable growth. Key growth stimuli include ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

German pharmaceutical giant Bayer BAYRY. Shares have skyrocketed 121.6% over the past year compared with the industry’s gain of 19.2%. The stock has also outperformed the sector and the S&P 500 Index ...

Bayer stock is poised to see strong buyer interest, as the company raised its peak sales forecast for new pharmaceutical drugs. Investor sentiment is also positively impacted by news that activist ...

Frankfurt, May 14 (Reuters) - Shares in Bayer were down 6.8 percent in early trade on Tuesday after a jury awarded more than $2 billion to a California couple in the largest U.S. jury verdict against ...

Also Read: FDA Grants Complete Approval To Bayer’s Drug For Certain Type Of Cancer With Mutation Bayer CFO Wolfgang Nickl said: "Based on the current status of tariffs announcements and our mitigation ...

There are no upcoming dividends for Bayer.The last dividend paid last dividend payout May 10, 2012 and was $1.56. Bayer has no upcoming dividends reported. The last reported dividend for Bayer (BAYRY) ...

A file photo taken on September 1, 2019 shows Roundup weedkiller on sale that is the subject of thousands of lawsuits in the U.S. Bayer stock rose on Tuesday after the U.S. solicitor general backed ...

Shares of Bayer BAYRY gained 12.1% after the Solicitor General supported a Supreme Court review of its Roundup weedkiller case in the United States. Bayer believes that the backing of the government ...